New York-based Immunai, a biotech that uses single-cell genomics and machine learning to discover and improve development of ...

US pharma major Eli Lilly has announced results from the primary overall survival (OS) analysis of the Phase III monarchE ...

Shares of China’s Hansoh Pharmaceutical edged up 2% to HK$36.50 as it announced a license agreement with Roche for HS-20110, ...

Anglo-Swedish pharma major AstraZeneca (LSE: AZN) has presented new data showing the impact of its PD-L1 inhibitor Imfinzi ...

USA-based Praxis Precision Medicines, a biopharma translating genetic insights into the development of therapies for central ...

USA-based clinical-stage dermatology start-up Veradermics has announced the completion of an oversubscribed $150 million ...

The European Medicine Agency’s (EMA) human medicines committee (CHMP) recommended two novel medicines for approval at its ...

German pharma group Merck (MRK: DE) has become the third company to strike a cost-cutting agreement with the Trump ...

US hematology specialist Disc Medicine surged 19.7% in after-hours trading Thursday after the company announced it received a ...

The European Parliament’s rapporteur has recently presented draft reforms to the proposed EU Critical Medicines Act, ...

The UK NHS Business Services Authority (NHSBSA) has released its latest General Services report. The report shows the ...